Cargando…
Effectiveness and tolerability of adjunctive perampanel in pediatric patients (aged 4–12 years) with refractory epilepsy: An observational study
Information on the effects of perampanel in Chinese children ≤12 years of age with refractory epilepsy is limited; thus, we conducted an observational study to assess the effectiveness, safety, and tolerability of adjunctive perampanel in this pediatric population. In this study, we reviewed the med...
Autores principales: | Chu, Si-Jia, Li, Yan, Tang, Ji-Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666151/ https://www.ncbi.nlm.nih.gov/pubmed/36397377 http://dx.doi.org/10.1097/MD.0000000000031408 |
Ejemplares similares
-
Efficacy and tolerability of adjunctive perampanel treatment in children under 12 years of age with refractory epilepsy
por: Yun, Yuni, et al.
Publicado: (2019) -
Effectiveness and safety of perampanel in adults with mesial temporal epilepsy: A single-center postmarketing study in Taiwan
por: Lin, Chih-Yin, et al.
Publicado: (2019) -
Adjunctive Perampanel Oral Suspension in Pediatric Patients From ≥2 to <12
Years of Age With Epilepsy: Pharmacokinetics, Safety, Tolerability, and
Efficacy
por: Renfroe, J. Ben, et al.
Publicado: (2019) -
Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023) -
Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)